BR112015004029A8 - processo para preparação de teneligliptina, de um composto ou de sal ou hidrato do mesmo, e, composto - Google Patents

processo para preparação de teneligliptina, de um composto ou de sal ou hidrato do mesmo, e, composto

Info

Publication number
BR112015004029A8
BR112015004029A8 BR112015004029A BR112015004029A BR112015004029A8 BR 112015004029 A8 BR112015004029 A8 BR 112015004029A8 BR 112015004029 A BR112015004029 A BR 112015004029A BR 112015004029 A BR112015004029 A BR 112015004029A BR 112015004029 A8 BR112015004029 A8 BR 112015004029A8
Authority
BR
Brazil
Prior art keywords
teneligliptin
preparing
hydrate
salt
compound
Prior art date
Application number
BR112015004029A
Other languages
English (en)
Other versions
BR112015004029A2 (pt
BR112015004029B1 (pt
Inventor
Parsottam Kansagra Bipin
Prakashrao Patil Jayant
Vishnu Kale Ramchandran
Nilkanth Bhadane Shailendra
Bhaskar Bhirud Shekhar
Mahadev Kadam Suresh
Popat Chaudhar Uddhav
Digamabar Patil Ulhas
Reddy Yemireddy Venkataramana
Original Assignee
Glenmark Generics Ltd
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd, Glenmark Pharmaceuticals Ltd filed Critical Glenmark Generics Ltd
Publication of BR112015004029A2 publication Critical patent/BR112015004029A2/pt
Publication of BR112015004029A8 publication Critical patent/BR112015004029A8/pt
Publication of BR112015004029B1 publication Critical patent/BR112015004029B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

1 / 1 resumo “processo para preparaã‡ãƒo de teneligliptina, de um composto ou de sal ou hidrato do mesmo, e, composto” um processo para preparaã§ã£o de teneligliptina por intermã©dio dos compostos intermediã¡rios das fã³rmulas 29 e 32.
BR112015004029-2A 2012-08-31 2013-08-28 Processo para preparação de teneligliptina, de um composto ou de sal ou hidrato do mesmo BR112015004029B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN2544/MUM/2012 2012-08-31
IN2544MU2012 2012-08-31
IN678MU2013 2013-03-06
IN678/MUM/2013 2013-03-06
PCT/IN2013/000527 WO2014041560A2 (en) 2012-08-31 2013-08-28 Process for the preparation of teneligliptin

Publications (3)

Publication Number Publication Date
BR112015004029A2 BR112015004029A2 (pt) 2017-08-22
BR112015004029A8 true BR112015004029A8 (pt) 2018-01-23
BR112015004029B1 BR112015004029B1 (pt) 2022-03-29

Family

ID=50278800

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015004029-2A BR112015004029B1 (pt) 2012-08-31 2013-08-28 Processo para preparação de teneligliptina, de um composto ou de sal ou hidrato do mesmo

Country Status (5)

Country Link
US (1) US9518048B2 (pt)
BR (1) BR112015004029B1 (pt)
MX (1) MX370649B (pt)
RU (1) RU2654069C2 (pt)
WO (1) WO2014041560A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015019238A1 (en) * 2013-08-06 2015-02-12 Ranbaxy Laboratories Limited Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one
WO2015173779A1 (en) 2014-05-16 2015-11-19 Micro Labs Limited Process for the preparation of teneligliptin and its novel intermediates
CN105294673B (zh) * 2014-06-18 2018-04-13 四川科伦药物研究院有限公司 一种氢溴酸替格列汀的合成方法
CN105085510B (zh) * 2015-09-11 2018-03-02 沧州那瑞化学科技有限公司 一种(s)‑4‑氧代‑2‑(噻唑烷‑3‑羰基)吡咯烷‑1‑羧酸叔丁酯的制备方法
CN106349237A (zh) * 2016-08-15 2017-01-25 南通普悦生物医药有限公司 氢溴酸特力利汀的制备方法
KR20180100554A (ko) * 2017-02-03 2018-09-11 그렌마크 파머수티칼스 엘티디. 테넬리글립틴의 옥살레이트 염 및 이의 용매화물을 포함하는 제형
JP2021522332A (ja) * 2018-04-25 2021-08-30 乳源▲東▼▲陽▼光▲薬▼▲業▼有限公司 テネリグリプチン臭化水素酸塩アモルファス及びその調製方法
CN108752277B (zh) * 2018-06-11 2020-11-24 浙江理工大学 一种1-(3-甲基-1-苯基-1h-吡唑-5-基)哌嗪的安全制备方法
JP7117975B2 (ja) * 2018-10-31 2022-08-15 沢井製薬株式会社 テネリグリプチン含有医薬組成物、テネリグリプチン含有医薬組成物の製造方法、テネリグリプチン含有錠剤及びテネリグリプチン含有錠剤の製造方法
CN109942571B (zh) * 2019-03-18 2021-11-16 深圳市第二人民医院 治疗糖尿病的药物特利列汀的制备方法
WO2021001695A1 (en) * 2019-03-21 2021-01-07 Accord Life Spec Private Limited An improved process for the preparation of teneligliptin hydrobromide hydrate
CN110028496A (zh) * 2019-04-26 2019-07-19 梯尔希（南京）药物研发有限公司 一种特力利汀相关杂质的合成方法
CN110294748B (zh) * 2019-07-25 2020-12-25 浙江沙星科技有限公司 一种替格列汀关键中间体的合成方法
JP2022069426A (ja) * 2020-10-23 2022-05-11 マイラン ラボラトリーズ リミテッド テネリグリプチン２．５臭化水素酸塩のアモルファスを調製する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4101053B2 (ja) * 2000-08-10 2008-06-11 田辺三菱製薬株式会社 プロリン誘導体及びその医薬用途
CN101119991B (zh) * 2005-02-18 2012-01-25 田边三菱制药株式会社 脯氨酸衍生物的盐，其溶剂合物，及其生产方法
BRPI0611074A2 (pt) * 2005-06-03 2010-11-23 Mitsubishi Tanabe Pharma Corp agentes farmacêuticos concomitantes e uso dos mesmos

Also Published As

Publication number Publication date
RU2015105294A (ru) 2016-10-20
RU2654069C2 (ru) 2018-05-16
MX370649B (es) 2019-12-19
BR112015004029A2 (pt) 2017-08-22
WO2014041560A2 (en) 2014-03-20
WO2014041560A3 (en) 2014-05-30
US9518048B2 (en) 2016-12-13
MX2015002487A (es) 2015-09-10
BR112015004029B1 (pt) 2022-03-29
US20150203484A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
BR112015004029A8 (pt) processo para preparação de teneligliptina, de um composto ou de sal ou hidrato do mesmo, e, composto
CR20140034A (es) Métodos para tratar el cáncer por el uso de antagonistas de unión al eje pd-1e inhibidores de mek
CL2014000731A1 (es) Metodo para producir derivados de 4,4-difluoro-3,4-dihidroisoquinolina
CL2014003526A1 (es) Métodos para tratar neoplasias resistentes al inhibidor tirosina quinasa en pacientes con polimorfismos genéticos o desregulaciones ahi1 o mutaciones que usan dianhidrogalactitol, diacetildianhidrogalactitol, dibromodulcitol o análogos o derivados de los mismos.
DK2922828T3 (da) 4,6-diamino-pyrimidin-derivater som bmi-1-inhibitorer til at behandle cancer
UY35683A (es) Polimorfo de inhibidores de tirosina quinasa de bazo (syk)
BR112014001418A2 (pt) compostos, processo para a preparação dos compostos, e, uso dos compostos
BR112014009302A2 (pt) processo para preparar derivativos de quinolina
BR112013030163A2 (pt) composto, uso cosmético de pelo menos um composto, composição farmacêutica ou cosmética e processo para preparar um composto.
BR112013031493A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto.
BR112013018945A2 (pt) processo para a preparação de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos.
BRDI7105799S (pt) Configuração aplicada em prendedor de cobertura de cabeça para conjunto de máscara nasal.
BR112015003101A2 (pt) processo para a preparação de um composto.
BR112013030994A2 (pt) uso de marcador raman para autenticação de documentos de segurança.
BR112013018942A2 (pt) processo para o preparo de 4-amino-3-cloro-5-fluro-6(substituído) picolinatos.
BR112015019667A2 (pt) método de produção de um composto, e, composto
BR112015008113A2 (pt) novo processo para preparar compostos para uso no tratamento de câncer.
BR112014010997A2 (pt) processo para o preparo de ß-glicosídeos de c-arila
BR112015007970A2 (pt) processo de preparação, sal de oxalato de (s)-2-hidroxi-1-(piperazin-1-il)propan-1-ona e invenção
BR112015001569A2 (pt) processo de preparação de alcoxifenol, processo de preparação de alcoxihidroxibenzaldeído e processo de preparação de pelo menos um composto alcoxihidroxibenzaldeído.
CR20140325A (es) Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2-
BRPI1005793A2 (pt) processo para preparar os 2-aminobifenis substituídos de fórmula i, composto de fórmula ia ou ib e processo para o preparo de pirazolecarboxamidas de fórmula iv
BRPI0917147A2 (pt) composto ou sal deste, uso de um composto ou sal deste, e, processo para fabricar um composto.
BR112014009437A2 (pt) processo para preparar um composto, composto e uso de um composto
BR112012021379A2 (pt) processo para a preparação de um alqueno

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/08/2013, OBSERVADAS AS CONDICOES LEGAIS.